
    
      The aim of the study was to evaluate the effectiveness of montelukast sodium in the treatment
      and prevention of recurrent obstructive bronchitis in children. The investigators examined 80
      children aged 1 to 7 years with recurrent obstructive bronchitis, who were randomly divided
      into 2 groups. Group I (control) included 40 patients who received standard therapy and
      placebo. Group II (main) included 40 patients who received standart therapy and oral
      montelukast sodium.
    
  